Financial statements Biotech Usa Polska
Balance sheet of Biotech Usa Polska
Company age:
Age:
11 y. 11 m. 29 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOTECH USA POLSKA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 6 492 300,97 | 5 452 703,20 | 9 531 490,10 |
| A. Fixed assets | 800 859,18 | 698 233,47 | 881 976,93 |
| B. Current assets | 5 691 441,79 | 4 754 469,73 | 8 649 513,17 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 6 492 300,97 | 5 452 703,20 | 9 531 490,10 |
| A. Equity | 206 936,97 | 935 534,98 | 1 929 656,02 |
| B. Liabilities and provisions for liabilities | 6 285 364,00 | 4 517 168,22 | 7 601 834,08 |
| I. Long-term liabilities | 0,00 | 0,00 | 8 500,00 |
| II. Short-term liabilities | 6 285 364,00 | 4 517 168,22 | 7 593 334,08 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD